Skip to main content
NCBI home page
Journal of Neurology, Neurosurgery, and Psychiatry logoLink to Journal of Neurology, Neurosurgery, and Psychiatry
. 1996 Feb;60(2):168–173. doi: 10.1136/jnnp.60.2.168

Lasting reduction of severe spasticity after ending chronic treatment with intrathecal baclofen.

J Dressnandt 1, B Conrad 1
PMCID: PMC1073798  PMID: 8708647

Abstract

OBJECTIVE--To investigate whether the dose of intrathecal baclofen necessary for a sufficient reduction of muscle tone and spasms changes during treatment of severe spasticity. METHODS--A group of 27 patients received intrathecal baclofen for 61 (SD 18) months. RESULTS--Spasticity remained absent or strongly reduced after stopping the intrathecal baclofen infusion in seven patients. The dose of baclofen could be reduced to 40% of that dose which was originally necessary in 10 patients. The dose remained the same or increased slightly in 10 patients. Possible reasons for the continuing reduction of spasticity after terminating long term intrathecal baclofen infusion in some patients could be: lasting morphological changes in spinal cord neurons by second messenger controlled modulation of gene expression, a toxic effect of baclofen on spinal neurons, muscular atrophy, inflammation due to the catheter, or progression of multiple sclerosis. CONCLUSIONS--A higher initial daily dose of intrathecal baclofen might lead to a faster, lasting suppression of spasticity and the development of spastic symptoms might even be prevented by pre-emptive treatment with baclofen in patients with newly acquired lesions of the spinal cord.

Full text

PDF
168

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ASHWORTH B. PRELIMINARY TRIAL OF CARISOPRODOL IN MULTIPLE SCLEROSIS. Practitioner. 1964 Apr;192:540–542. [PubMed] [Google Scholar]
  2. Allerton C. A., Boden P. R., Hill R. G. Actions of the GABAB agonist, (-)-baclofen, on neurones in deep dorsal horn of the rat spinal cord in vitro. Br J Pharmacol. 1989 Jan;96(1):29–38. doi: 10.1111/j.1476-5381.1989.tb11780.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bowery N. G., Pratt G. D. GABAB receptors as targets for drug action. Arzneimittelforschung. 1992 Feb;42(2A):215–223. [PubMed] [Google Scholar]
  4. Castro-Lopes J. M., Tavares I., Tölle T. R., Coimbra A. Carrageenan-induced inflammation of the hind foot provokes a rise of GABA-immunoreactive cells in the rat spinal cord that is prevented by peripheral neurectomy or neonatal capsaicin treatment. Pain. 1994 Feb;56(2):193–201. doi: 10.1016/0304-3959(94)90094-9. [DOI] [PubMed] [Google Scholar]
  5. Castro-Lopes J. M., Tavares Isaura, Tölle T. R., Coito Ana, Coimbra A. Increase in GABAergic Cells and GABA Levels in the Spinal Cord in Unilateral Inflammation of the Hindlimb in the Rat. Eur J Neurosci. 1992;4(4):296–301. doi: 10.1111/j.1460-9568.1992.tb00877.x. [DOI] [PubMed] [Google Scholar]
  6. Coffey J. R., Cahill D., Steers W., Park T. S., Ordia J., Meythaler J., Herman R., Shetter A. G., Levy R., Gill B. Intrathecal baclofen for intractable spasticity of spinal origin: results of a long-term multicenter study. J Neurosurg. 1993 Feb;78(2):226–232. doi: 10.3171/jns.1993.78.2.0226. [DOI] [PubMed] [Google Scholar]
  7. Dolphin A. C., Scott R. H. Inhibition of calcium currents in cultured rat dorsal root ganglion neurones by (-)-baclofen. Br J Pharmacol. 1986 May;88(1):213–220. doi: 10.1111/j.1476-5381.1986.tb09489.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Dressnandt J., Auer C., Conrad B. Influence of baclofen upon the alpha-motoneuron in spasticity by means of F-wave analysis. Muscle Nerve. 1995 Jan;18(1):103–107. doi: 10.1002/mus.880180114. [DOI] [PubMed] [Google Scholar]
  9. Kangrga I., Jiang M. C., Randić M. Actions of (-)-baclofen on rat dorsal horn neurons. Brain Res. 1991 Oct 25;562(2):265–275. doi: 10.1016/0006-8993(91)90630-e. [DOI] [PubMed] [Google Scholar]
  10. Kangrga I., Jiang M. C., Randić M. Actions of (-)-baclofen on rat dorsal horn neurons. Brain Res. 1991 Oct 25;562(2):265–275. doi: 10.1016/0006-8993(91)90630-e. [DOI] [PubMed] [Google Scholar]
  11. Kroin J. S., Bianchi G. D., Penn R. D. Intrathecal baclofen down-regulates GABAB receptors in the rat substantia gelatinosa. J Neurosurg. 1993 Oct;79(4):544–549. doi: 10.3171/jns.1993.79.4.0544. [DOI] [PubMed] [Google Scholar]
  12. Kroin J. S., Penn R. D., Beissinger R. L., Arzbaecher R. C. Reduced spinal reflexes following intrathecal baclofen in the rabbit. Exp Brain Res. 1984;54(1):191–194. doi: 10.1007/BF00235831. [DOI] [PubMed] [Google Scholar]
  13. Loubser P. G., Narayan R. K., Sandin K. J., Donovan W. H., Russell K. D. Continuous infusion of intrathecal baclofen: long-term effects on spasticity in spinal cord injury. Paraplegia. 1991 Jan;29(1):48–64. doi: 10.1038/sc.1991.7. [DOI] [PubMed] [Google Scholar]
  14. Meythaler J. M., Steers W. D., Tuel S. M., Cross L. L., Haworth C. S. Continuous intrathecal baclofen in spinal cord spasticity. A prospective study. Am J Phys Med Rehabil. 1992 Dec;71(6):321–327. doi: 10.1097/00002060-199212000-00003. [DOI] [PubMed] [Google Scholar]
  15. Ochs G., Struppler A., Meyerson B. A., Linderoth B., Gybels J., Gardner B. P., Teddy P., Jamous A., Weinmann P. Intrathecal baclofen for long-term treatment of spasticity: a multi-centre study. J Neurol Neurosurg Psychiatry. 1989 Aug;52(8):933–939. doi: 10.1136/jnnp.52.8.933. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Penn R. D. Intrathecal baclofen for spasticity of spinal origin: seven years of experience. J Neurosurg. 1992 Aug;77(2):236–240. doi: 10.3171/jns.1992.77.2.0236. [DOI] [PubMed] [Google Scholar]
  17. Penn R. D., Kroin J. S. Intrathecal baclofen alleviates spinal cord spasticity. Lancet. 1984 May 12;1(8385):1078–1078. doi: 10.1016/s0140-6736(84)91487-9. [DOI] [PubMed] [Google Scholar]
  18. Sallerin-Caute B., Lazorthes Y., Monsarrat B., Cros J., Bastide R. CSF baclofen levels after intrathecal administration in severe spasticity. Eur J Clin Pharmacol. 1991;40(4):363–365. doi: 10.1007/BF00265844. [DOI] [PubMed] [Google Scholar]
  19. Tölle T. R., Herdegen T., Schadrack J., Bravo R., Zimmermann M., Zieglgänsberger W. Application of morphine prior to noxious stimulation differentially modulates expression of Fos, Jun and Krox-24 proteins in rat spinal cord neurons. Neuroscience. 1994 Jan;58(2):305–321. doi: 10.1016/0306-4522(94)90037-x. [DOI] [PubMed] [Google Scholar]
  20. Wilson P. R., Yaksh T. L. Baclofen is antinociceptive in the spinal intrathecal space of animals. Eur J Pharmacol. 1978 Oct 15;51(4):323–330. doi: 10.1016/0014-2999(78)90423-5. [DOI] [PubMed] [Google Scholar]
  21. Yaksh T. L., Reddy S. V. Studies in the primate on the analgetic effects associated with intrathecal actions of opiates, alpha-adrenergic agonists and baclofen. Anesthesiology. 1981 Jun;54(6):451–467. doi: 10.1097/00000542-198106000-00004. [DOI] [PubMed] [Google Scholar]
  22. Zierski J., Müller H., Dralle D., Wurdinger T. Implanted pump systems for treatment of spasticity. Acta Neurochir Suppl (Wien) 1988;43:94–99. doi: 10.1007/978-3-7091-8978-8_21. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Neurology, Neurosurgery, and Psychiatry are provided here courtesy of BMJ Publishing Group

RESOURCES